INFLUENCE OF VARIOUS TYPES OF ANESTHESIA IN ONCOSURGICAL PRACTICE ON IMMUNE PARAMETERS

Cover Page

Abstract


The aim of investigation is to reveal dependence of indicators of a phagocytes-macrophageal link and cytokine regulation at the operated patients with malignant new growths from a way of anesthesia. 274 patients with a gastroenteric cancer which was exposed to radical operative interventions with use of various ways of anesthesia (total intravenous, inhalation and intravenous-epidural) are surveyed. Existence of dependence of indicators of a phagocytes link of immunity and cytokine regulation from a way of surgical anesthesia at oncological patients is revealed. Most the imbalance of the studied phagocytes and cytokine mechanisms was shown at total intravenous, in the smallest – at combined intravenous epidural anesthesia that serves one of factors for the recommendation of its priority use in oncosurgical practice.

 


About the authors

S. Z. Tanatarov

Semey Medical University, Republic of Kazakhstan

Author for correspondence.
Email: sayat68@mail.ru

Russian Federation Candidate of Medical Sciences, Head Of Anesthesiology and Resuscitation, Regional Oncology Clinic, Semey; Assistant Lecturer, Chair Of Anesthesiology And Resuscitation, State Medical University, Semey Address: 014700, Kazakhstan Republic, Semey, Kulzhanova str. 3; Tel.: (7222) 77-44-18

M. I. Neunmark

Altay State Medical University, Barnaul, Russian Federation

Email: mineimark@mail.ru

Russian Federation PhD, Professor, Head of a Chair of Anesthesiology and Resuscitation, Altay State Medical University Address: 656039, Barnaul, Lenin avenue, 40; Tel.: (3852) 36-88-48, Fax: (3852) 36-60-91

R. K. Zhakupov

Medical University of Astana, Republic of Kazakhstan

Email: far_1@mail.ru

Russian Federation PhD, Professor, Head of a Chair of Anesthesiology and Resuscitation #1, Medical University, Astana Address: 010000, Astana, Beybytshylyk avenue, 49A; Tel.: (7172) 53-94-24, Fax: (7172) 53-94-53

References

  1. Elkord E., Alcantar-Orozco E.M., Dovedi S.J., Tran D.Q., Hawkins R.E., Gilham D.E. T regulatory cells in cancer: recent advances and therapeutic potential. Exp. Opin. Biol. Ther. 2010; 10 (11): 1573–1586.
  2. Kim R., Emi M., Tanabe K. Cancer immunosuppression and autoimmune disease: beyond immunosuppressive networks for tumour immunity. Immunology. 2006; 119 (2): 254–264.
  3. Kopecky J, Slovacek L, Priester P., Slovackova B., Kopecky O. Changes in immune reactivity in cancer patients. Clin. Onkol. 2012; 25 (2): 97–102.
  4. Blindar' V.N., Zubrikhina G.N. Modern understanding of the role of neutrophils in antitumor immunity (review). Klin. lab. diagnostika = Clinical laboratory diagnostics. 2005; (8): 51–54.
  5. Teletaeva G.M. Cytokines and anti-tumor response. Prakt. onkol. = Practical oncology. 2007; 8 (4): 211–218.
  6. Setdikova N.Kh., Latysheva T.V., Pinegin B.V., Il'ina N.I. Immunodefitsity: printsipy diagnostiki i lecheniya [Immunodeficiencies: Principles of Diagnosis and Treatment]. Moscow, Farmarus-Print, 2006. 20 p.
  7. Griffis C.A., Page G., Kremer M., Yermal S. Implications of immune function to anesthesia care. AANA J. 2008; 76 (6): 449–454.
  8. Sharp B.M. Opioid receptor expression and intracellular signaling by cells involved in host defense and immunity. Adv. Exp. Med. Biol. 2003; 521: 98–105.

Statistics

Views

Abstract - 356

PDF (Russian) - 142

Cited-By


Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM

PlumX

Dimensions



Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies